| 2011: | Center principal investigator of a multinational Asthma trial (Fase IIb-III) |
| 2011: | Co-Leader of project: Ideal concentration of Histamine positive control for skin prick testing. Endorsed by AAAAI2. |
| 2010: | Leader of project: Allergen extract stability with different diluent as tested in intra-dermal skin testing. Supported by ACAAI3 and endorsed by AAAAI2. |
| 2009: | Leader of the project: Blinded study of allergic rhinitis and skin test sensitivity in Mexico: 26 study centers. Supported by Mexican College of Allergy (CMICA4). |
| 2008: | Leading coordinator of the multinational WAO1 –AAAAI2-ACAAI3 supported project: Extract potency in SPT: European–American comparison, phase III Comparisons in Skin testing in 3 different countries. |
| 2007-2010: | Leader of the project: Extract potency in vitro: European–American comparison, phase II comparisons in vitro testing in 6 labs in US. Published. |
| 2005-2006: | Leader of the project: Extract potency: European–American comparison, phase I, Published |
| 2006-2010: | Leader of the project Cat extract potency in SPT: Mexican-European comparison against FDA. Pubmed publ 2010 |
| 2007-2010: | Leader of the project: Bermuda grass pollen extract potency in SPT: Mexican-European comparison against FDA. Pubmed publ 2010 |
| 2006-2009: | Leader of the project: House dust mite extract potency in SPT: Mexican-European comparison against FDA. Pubmed publ 2010 |
| 2005-2006: | Leader of the project of ‘Estudio de 100 pruebas’ and of ‘Potencia in vitro de extractos alergénicos mexicanos’. Published 2010 |
| 2005: | Leader of the project ‘Encuesta Nacional Mexicana de Inmunoterapia’. Total results presented in 4 different pubmed publications. |
| 2002-2003: | Principal investigator at my hospital Médica Sur, of the pharmacokinetic study of (des)loratadina. (S.P. Research Institute) |
| 1998-1999: | National coordinator of a multinational study on Oxis – Pulmicort for COPD |
| 1998-1999: | Principal investigador of ‘CASA-1 and CASA-2, prospective studies on Symptom and lung function improvement with Pulmicort in asthmatic patients (=Clinical phase 4 studies.). Principal investigator of ‘CASEPOC, national study of bronchodilator use in COPD (design and coordination of nacional implementation) |
| 1997-1998: | National coordinator of OPTIMA (=multinacional study on asthma) |
| 1997-1998: | Co-investigator of ‘Impact of a mixing center on the prescribing conduct of physicians.’ |
| 1997: | Principal investigador of ‘Con Astra sin Asma’, prospective study on Pulmicort in asthma patients |
| 1996: | Retrospective chart review of subcutaneous immunotherapy in the treatment of atopic dermatitis. |
| 1996: | Allergic manifectations as markers of disease activity in HIV infected childern. Prospective study. |
| 1996: | Prospective study: Language development in allergic patients. |
| 1996: | Retrospective study: Language development in allergic patients. |
| 1995: | Knowledge of Mexican allergists of the treatment of asthmatic crisis. |
| 1995: | Inhaler use technique of asthmatic children and the impact of video instructions and drawing. |
| 1994: | Pediatric Thesis: Niemann-Pick disease, 25 years of experience in a tertiary hospital. |
| 1989: | Children with cough in Mafeteng, from home to the hospital. Lesotho (Southern Africa). Postdoc thesis. |
| 1986: | Principal investigador of ‘Estadio nutricional de niños de 0-5años y el conocimiento de la madre acerca de la nutrición de ellos en tres barrios marginales en Quito, Ecuador’ |
Received the following awards:
Prime author and co-author of several in-depth review articles, guidelines and consensus in the field of allergy and allergen immunotherapy. Please refer to list of publications.
Doctora Désirée Larenas Linnemann
Alergia, asma y pediatría
Teléfono: 5171 2248
Médica Sur, consultorio 602, Torre II, Sexto Piso
Lunes a Sábado 8:00 a 13:30 hrs. / Miércoles 14:00 a 19:30 hrs.